Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Exclusive-Hedge fund Irenic asks Capricorn Energy to ditch NewMed deal

Published 10/19/2022, 02:14 PM
Updated 10/19/2022, 02:15 PM
© Reuters

By Svea Herbst-Bayliss

(Reuters) -Irenic Capital Management, a hedge fund that owns a 1.5% stake in Capricorn Energy Plc, asked the natural gas producer on Wednesday to abandon its sale to Israel's NewMed Energy LP in favor of selling its assets piecemeal.

Irenic's intervention challenges a deal that would create a London and Tel Aviv-listed gas giant, at a time when European countries are looking for such companies to help with a supply crunch caused by Russia's invasion of Ukraine.

Irenic told Capricorn's board in a letter seen by Reuters that a liquidation, in which the company would auction off its assets, can deliver a 43% premium relative to its current share price and a nearly 40% premium relative to the NewMed deal.

Capricorn and NewMed spokespeople did not immediately respond to requests for comment.

The company's stock price closed up 0.25% at 244.60 pence

The NewMed transaction would result in Capricorn being paid a $620 million special dividend. It would also leave them with a 10.3% stake in the combined company, with NewMed shareholders owning 89.7%. Excluding the special dividend, the deal values Capricorn at $338 million.

A liquidation could value Capricorn's assets at 350 pence per share, versus the 254 pence-per-share valuation in the NewMed deal, according to Irenic.

"The company has yet to present shareholders with any proposal that represents superior value relative to the straightforward liquidation value we have assessed," Irenic wrote in the letter.

Adam Katz, one of the firm's partners, plans to present his thesis at the SohnX San Francisco investment conference later on Wednesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Capricorn has had to abandon a deal before because of shareholder opposition. Prior to agreeing on a sale to NewMed, Capricorn scrapped plans to merge with Tullow Oil Plc (LON:TLW) in a deal that would have valued Capricorn shares at 210 pence and would have given Capricorn investors 47% of the new entity. Large Capricorn investors, including Schroders (LON:SDR) and Madison Avenue Partners, argued there were few synergies between the two companies.

NewMed holds a 45.3% stake in the giant Leviathan field off the coast of Israel, the largest gas reservoir in the Mediterranean.

Irenic said it views NewMed's assets as more attractive than Tullow's but noted that "their value remains highly uncertain." It added that the merger appeared to have "limited strategic rationale" beyond offering NewMed with a premium listing on the London Stock Exchange.

Irenic, a new activist hedge fund founded last year by former Elliott Management and Indaba Capital Management executives, has been making headlines in the last weeks by pushing industrial and aerospace manufacturer Barnes Group (NYSE:B) Inc to refresh its board and consider selling all or parts of the company and by calling on News Corp (NASDAQ:NWSA) to split its media and real estate units as it considers reuniting with Fox Corp.

Katz, who worked at Elliott, and Andy Dodge, a former Indaba partner, have raised roughly $500 million in assets across various funds, sources familiar with Irenic's fund said.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.